Human Genome Epidemiology Literature Finder
Cancer
|
Records 1 - 30 (of 9888 Records) |
| Query Trace: Breast Cancer[original query] |
|---|
| A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers. PloS one 2023 11 18 (11): e0292611. Neda Zamani, Agata Szymiczek, Ramin Shakeri, Hossein Poustchi, Akram Pourshams, Steven Narod, Reza Malekzadeh, Mohammad R Akba |
| Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study. eLife 2023 11 12 . Yajing Chi, Mu Su, Dongdong Zhou, Fangchao Zheng, Baoxuan Zhang, Ling Qiang, Guohua Ren, Lihua Song, Bing Bu, Shu Fang, Bo Yu, Jinxing Zhou, Jinming Yu, Huihui |
| The Investigation of the Association Between the Bcl-2 3'-UTR rs1564483 Polymorphism and miR-296-3p in the Development of Breast and Gastric Cancers. Clinical Medicine Insights. Oncology 2023 11 17 11795549231207835. Mehrnoush Azadeh Jouneghani, Fatemeh Keshavarzi, Nahid Haghnazari, Zahra Hooshmandi, Sabrieh Ami |
| Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study. Discover. Oncology 2023 11 14 (1): 198. Zhizhou Li, Maoyu Wang, Meimian Hua, Ziwei Wang, Yidie Ying, Zhensheng Zhang, Shuxiong Zeng, Huiqing Wang, Chuanliang |
| Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma. BMC cancer 2023 11 23 (1): 1061. Aurélien Drouyer, Ludivine Beaussire, Pauline Jorda, Marianne Leheurteur, Cécile Guillemet, Anca Berghian, Dragos Georgescu, Frédéric Di Fiore, Anne Perdrix, Florian Clat |
| Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study. Free radical biology & medicine 2023 11 209 (Pt 2): 381-393. David J Hughes, Lutz Schomburg, Mazda Jenab, Carine Biessy, Catherine Méplan, Aurelie Moskal, Qian Sun, Kamil Demircan, Veronika Fedirko, Elisabete Weiderpass, Maryam Mukhtar, Anja Olsen, Anne Tjønneland, Kim Overvad, Matthias Schulze, Therese Haugdahl Nøst, Guri Skeie, Karina Standahl Olsen, Fulvio Ricceri, Sara Grioni, Domenico Palli, Giovanna Masala, Rosario Tumino, Fabrizio Pasanisi, Pilar Amiano, Sandra M Colorado Yohar, Antonio Agudo, Maria-Jose Sánchez, Eva Ardanaz, Malin Sund, Anne Andersson, Aurora Perez-Cornago, Ruth Travis, Alicia K Heath, Laure Doss |
| The uncharted role of HER2 mutant alleles in breast cancer. Oncotarget 2023 11 14 904-907. Rashi Kalra, Bora Lim, Matthew J Ellis, Shyam M Kavu |
| Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The oncologist 2023 11 . Jiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, Laura Min Xuan Chai, Mei-Hsuan Lee, Chun-Yu Liu, Yi-Fang Tsai, Chi-Cheng Huang, Ling-Ming Tseng, Cheng-Chih Hsu, Ta-Chung Ch |
| Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature. JCO precision oncology 2023 11 7 e2300091. Felipe Batalini, Russell W Madison, Ethan S Sokol, Dexter X Jin, Kuei-Ting Chen, Brennan Decker, Dean C Pavlick, Garrett M Frampton, Gerburg M Wulf, Judy E Garber, Geoffrey Oxnard, Alexa B Schrock, Nadine M Tu |
| Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
| ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer. Cancer discovery 2023 11 . Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, Li-Xuan Sim, Rosalind J Cutts, Heena Shah, Laura Moretti, Lucy S Kilburn, Hannah Johnson, Iain R Macpherson, Alistair Ring, Judith M Bliss, Yingwei Hou, Weiyi Toy, John A Katzenellenbogen, Sarat Chandarlapaty, Nicholas C Turn |
| Genomic analysis of breast cancer patients from Kerala: A novel BRCA1 mutation detected. Breast disease 2023 11 42 (1): 341-347. Adarsh Dharmarajan, Vipin Gopinath, Sangeetha Keloth Nayanar, Sobhith Velandi Kunnummal, Satheesan Balasubramanian, Deepak Roshan Valiyaparambil Go |
| Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications 2023 11 14 (1): 7496. P Tarantino, H Gupta, M E Hughes, J Files, S Strauss, G Kirkner, A-M Feeney, Y Li, A C Garrido-Castro, R Barroso-Sousa, B L Bychkovsky, S DiLascio, L Sholl, L MacConaill, N Lindeman, B E Johnson, M Meyerson, R Jeselsohn, X Qiu, R Li, H Long, E P Winer, D Dillon, G Curigliano, A D Cherniack, S M Tolaney, N U L |
| Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal transduction and targeted therapy 2023 11 8 (1): 429. Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe |
| Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis 2023 11 238 115839. Fatemeh Saghafi, Ebrahim Salehifar, Pouneh Ebrahimi, Mohammad Reza Shiran, Ehsan Zaboli, Seyed Mojtaba Sohrevardi, Tannaz Jamialahmadi, Adeleh Sahebnasagh, Amirhossein Sahebk |
| Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib. JCO precision oncology 2023 11 7 e2300295. Malini M Gandhi, Biagio Ricciuti, Guilherme Harada, Matteo Repetto, Melissa S Gildenberg, Ankit Singh, Yvonne Y Li, Andréanne Gagné, Xinan Wang, Ayal Aizer, Kelly Fitzgerald, Mizuki Nishino, Joao Alessi, Federica Pecci, Alessandro Di Federico, Adam Fisch, Alexander Drilon, Valentina Nardi, Lynette Sholl, Mark M Awad, Julia Rot |
| The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? Annals of translational medicine 2023 11 11 (11): 393. Stanislas Quesada, William Jac |
| GSK3? rs3107669 polymorphism implicates chemotherapy-associated retrospective memory deficits in breast cancer survivors. American journal of cancer research 2023 11 13 (10): 4961-4975. Wen Li, Chen Gan, Sheng Yu, Jian Xu, Lingxue Tang, Qiang Li, Zhenwei Zhu, Huaidong Che |
| Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. American journal of translational research 2023 11 15 (10): 6026-6041. Jiaoping Mi, Juncong Luo, Huanwen Zeng, Hongyu Zhang, Muhammad Jamil, Mostafa A Abdel-Maksoud, Adel M Zakri, Akram A Alfuraydi, Ning Zhang, Mei Xi |
| Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer. Acta oncologica (Stockholm, Sweden) 2023 11 1-8. Frances M Reznitsky, Jeanette D Jensen, Ann Knoop, Maj-Britt Jensen, Anne-Vibeke Laenkho |
| The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International journal of molecular sciences 2023 11 24 (21): . Paolo Aretini, Silvano Presciuttini, Aldo Pastore, Alvaro Galli, Sara Panepinto, Mariella Tancredi, Matteo Ghilli, Chiara Guglielmi, Diletta Sidoti, Caterina Congregati, Maria Adelaide Cali |
| Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience. Hereditary cancer in clinical practice 2023 11 21 (1): 23. Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagaya |
| The association between thyroid and breast cancers: a bidirectional mendelian randomization study. Frontiers in endocrinology 2023 11 14 1185497. Jinchi Liu, Leifeng Lia |
| Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease. Gene 2023 11 147980. Ashish Singh, Josh Thomas Georgy, Sakthi Dhananjayan, Elanthenral Sigamani, Ajoy Oommen John, Anjana Joel, Jagan Chandramohan, Rajadurai Abarna, Grace Rebekah, Selvamani Backianathan, Deepak Thomas Abraham, Mazhuvanchary Jacob Paul, Raju Titus Chacko, Marie Therese Manipadam, Rekha P |
| CYP2D6 genotyping and the clinical impact on outcomes in breast cancer tamoxifen-treated patients. Personalized medicine 2023 11 . Gabriel Ramírez, Marcelo Vital, Carolina Vergara, Florencia Carusso, Florencia Neffa, Adriana Della Valle, Patricia Esper |
| Breast cancer risk is associated with the HULC rs7763881, MTMR3 rs12537 polymorphisms, and serum levels of HULC and MTMR3 in Egyptian patients. Molecular biology reports 2023 11 . Mona Elhelaly, Olfat G Shaker, Ghada Ayeldeen, Alyaa R Elsergany, Nora Mosta |
| Ancestry and self-reported race in Brazilian breast cancer women. Revista da Associacao Medica Brasileira (1992) 2023 11 69 (12): e20230767. René Aloisio da Costa Vieira, Débora Sant'Anna, Ana Carolina Laus, Rui Manuel Re |
| Low rate of complications in nipple-sparing mastectomy for patients with BRCA1 and BRCA2 mutation. Personalized medicine 2023 11 . Antônio Luiz Frasson, Ana Beatriz Falcone, Fernanda Barbosa, Alessandra Borba Anton de Souza, Carolina Malhone, Isabela Miranda, Betina Vollbrecht, Monica Adriana Rodriguez Martinez Frasson, Luiza Kobe, Martina Lichtenfe |
| Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer. Annals of surgical oncology 2023 10 . Amy K Schulze, Tanya L Hoskin, Dan Moldoveanu, Jenna L Sturz, Judy C Bough |
| A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer. Breast care (Basel, Switzerland) 2023 10 18 (5): 412-416. Paulina Gebhart, Yen Tan, Daniela Muhr, Christina Stein, Christian Sing |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: